Belo, R., Santarém, N., Pereira, C., Pérez-Cabezas, B., et al. (2017). Leishmania infantum exoproducts inhibit human invariant NKT cell expansion and activation. Frontiers in Immunology, 8(JUN).

Faria, J., Loureiro, I., Santarém, N., Macedo-Ribeiro, S., et al. (2016). Leishmania infantum Asparagine Synthetase A Is Dispensable for Parasites Survival and Infectivity. PLoS Neglected Tropical Diseases, 10(1).

Gazanion, E., Garcia, D., Silvestre, R., Gérard, C., et al. (2011). The Leishmania nicotinamidase is essential for NAD + production and parasite proliferation. Molecular Microbiology, 82(1), 21 - 38.

Tavares, J., Ouaissi, A., Santarém, N., Sereno, D., et al. (2008). The Leishmania infantum cytosolic SIR2-related protein 1 (LiSIR2RP1) is an NAD+-dependent deacetylase and ADP-ribosyltransferase. Biochemical Journal, 415(3), 377 - 386.

Menezes Cabral, S., Leal Silvestre, R., Moreira Santarém, N., Costa Tavares, J., et al. (2008). A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin. Immunology, 123(4), 555 - 565.

Silvestre, R., Cordeiro-da-Silva, A., & Ouaissi, A. (2008). Live attenuated Leishmania vaccines: A potential strategic alternative. Archivum Immunologiae et Therapiae Experimentalis, 56(2), 123 - 126.

Silvestre, R., Cordeiro-da-Silva, A., Tavares, J., Sereno, D., & Ouaissi, A. (2006). Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies. Immunology, 119(4), 529 - 540.